What question did this study set out to answer?

March 5, 2026

Clinical Outcomes of Intra-Abdominal Candidiasis by Initial Antifungal Therapy.

Key Points

This research aims to evaluate the clinical outcomes of intra-abdominal candidiasis based on initial antifungal therapy.
Comparison of initial antifungal therapies in patients with intra-abdominal candidiasis
Assessment of clinical outcomes such as mortality and need for re-intervention
Evaluation of culture results and severity of infection
No significant mortality difference between initial echinocandin and azole treatment
Persistent positive cultures linked to more severe infections
Severe presentations led to more frequent re-intervention and higher mortality rates

Abstract

IAC remains a complex infection with substantial morbidity and mortality. Echinocandins are preferred in critically ill patients, but mortality did not differ significantly between initial echinocandin and azole treatment. Persistent positive cultures were linked to severe presentation, including peritonitis, candidemia, and septic shock, which required more frequent re-intervention, and consequently carried higher mortality.

Bookmark

Cite This Study

Albanell-Fernández et al. (Sun,) studied this question.

synapsesocial.com/papers/69a91e2cd6127c7a504c1d53 https://doi.org/https://doi.org/10.1111/myc.70147

Bookmark